The Netherlands Cancer Institute
|
Antoni van Leeuwenhoek Ziekenhuis
home
|
contact
|
staff members
|
sitemap
|
vacancies
|
search
Home
>
About the Netherlands Cancer Institute
>
History
History NKI-AVL
The Netherlands Cancer Institute
Antoni van Leeuwenhoek
08-30-2006
|
The Netherlands Cancer Institute
About the Netherlands Cancer Institute
Welcome by the scientific director
The history of The Netherlands Cancer Institute
The Netherlands Cancer Institute
Antoni van Leeuwenhoek
Leadership
Patron
Board of Governors
Board of Directors
Management Team
Scientific Advisory Board
Research Council
Faculty Council
Administrative departments
Scientific report
Faculty and Research
Faculty
Divisions
Immunology
Gene Regulation
Cell Biology I
Cel Biology II
Molecular Carcinogenesis
Biochemistry
Molecular Biology
Molecular Genetics
Experimental Therapy
Psychosocial Research and Epidemiology
Radiotherapy
Medical Oncology
Surgical Oncology
Diagnostic Oncology
Clinical Research
NKI comprehensive cancer center
Centre for Biomedical Genetics
Cancer Genomics Center
International BRCA1 -2 Carrier Cohort Study (IBCCS)
Support facilities
Library
Amsterdam Breast Cancer Study (ABCS)
News and Communication
News
Two million euros to fight lung cancer
Vici grant for chromosome organisation
Mirjam Epping receives Rubicon
Ton Schumacher receives grant
How inflammatory proteins can protect against cancer
Discovery of several hundreds of potential cancer genes
Thesis Anja Duursma
Thesis Anna Keller
Vidi-grants for Elisabetta Citterio and Karin de Visser
Genetic profiling breast cancer
Appointment Professor Daniel Peeper
Appointment Professor John Haanen
European Comprehensive Cancer Center Alliance (ECCCA)
Thesis Nuno Rocha
Thesis defence Annelies Jorritsma
Appointment Professor Reuven Agami
Biomarker associated with poor outcome in aggressive childhood cancer
Collaboration between NKI-AVL AstraZeneca and Agendia wins Best Partnership Alliance Award
coorperating oncogenes
Impact blood-brain barrier in brain tumor chemotherapy
Mechanism of melanoma formation elucidated
NKI withdraws two scientific publications
Press releases
HFSP Research Grant for Ton Schumacher
Vidi-grants for Elisabetta Citterio and Karin de Visser
Discovery of several hundreds of potential cancer genes
A novel family of antibiotics
EMBO welcomes fifty leading scientists
Top cancer grant to NKI-AvL researcher Daniel Peeper
p15 critical tumour suppressor in absence of p16
In biology polarization is a good thing
How inflammatory proteins can protect against cancer
EMBO honours Daniel Peeper and Bas van Steensel as leading life scientists
European Comprehensive Cancer Centre Alliance (ECCCA)
New tumor inhibitor for treatment of hereditary breast cancer shows promising results
Mechanism of melanoma formation elucidated
Publications
Scientific brochure
General brochure
Scientific report
Contact us
Image gallery
Archive news
Archive news 2007
Archive news 2006
Archive news 2008
Archive Press releases
2007
2006
Seminars and Events
Scientific seminars
Scientific meetings
Events
Absolute Risk Prediction
Workshop on Innovative Mouse Models
Calendar
Career & Training
Faculty
Postdoctoral fellows
Graduate students
Masters students
Vacancies
Faculty
Postdoctoral Fellows
Graduate Students
Technicians and Research support personnel
Other
senior technology transfer manager
Technology Transfer
Information for businesses
Key technology areas
Licensing opportunities
Reagents
Spin outs
Information for patients - Informatie voor patiënten
The team
Contact